[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL GROUP, MULTICENTER TRIAL OF CVL-865 AS ADJUNCTIVE THERAPY IN ADULTS WITH DRUG-RESISTANT FOCAL ONSET SEIZURES

What is the purpose of the study?

To evaluate the efficacy of CVL-865 as adjunctive therapy compared with placebo in subjects with focal onset seizures.

Upstate Institutional Review Board (IRB) Number:

1539947

Study/Protocol ID:

CVL-865-SZ-001

Patient Age Group:

Adults

Principal Investigator:

Robert L Beach

What is involved if I participate?

  • How long is the study?
    Approximately 4 months.

ClinicalTrials.Gov ID:

NCT04244175

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Marielle N Posmik
Phone: 315-464-1670
Email: Posmikm@upstate.edu

Return to Previous Page || Search Again

Top